QA: Paratek Pharmaceuticals Inc in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001178711_2018_Paratek_Pharmaceuticals_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001178711, Paratek Pharmaceuticals Inc

  xvar xval
0 AssetsCurrent 160,486,000
1 IntangibleAssetsNetIncludingGoodwill 971,000
2 PropertyPlantAndEquipmentNet 1,711,000
3 remainder_Assets 530,000
4 LiabilitiesCurrent 16,789,000
5 LiabilitiesNoncurrent 64,360,000
6 remainder_Liabilities 71,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 37,558,527
9 ResearchAndDevelopmentExpense 54,336,616
10 remainder_Expenses 6,276,222
11 remainder_Revenues 10,779,867
12 remainder_NetIncome 1,279,065
13 remainder_ComprehensiveNetIncome -190,244
  yvar yval
0 Assets 163,698,000
1 Liabilities 81,220,000
2 Expenses 98,171,365
3 Revenues 10,779,867
4 StockholdersEquity 82,478,000
5 NetIncome -86,112,433
6 ComprehensiveNetIncome -86,207,555
7 BaseVar 177,669,270
8 EconomicCapitalRatiobeforeLimitedLiability 0.764
9 EconomicCapitalRatio 2.11

Edgar->Model Mapping

Feature Distribution

Change over Time